Qualitative Nucleic Acid Amplification Test (NAAT)
Measles is a highly communicable respiratory disease characterized by symptoms such as fever, malaise, cough, conjunctivitis, coryza, Koplik spots, and a maculopapular rash that radiates downward from the head. , Molecular testing can be used to diagnose measles infection and differentiate a rash induced by a recent vaccination from a wild-type measles virus infection. Samples for RNA detection should be collected as soon as possible after rash onset, as viral shedding declines with time after rash.
Test Interpretation
Analytic Sensitivity/Specificity
Real-time PCR tests for measles allow for earlier detection of the virus as compared to measles IgM antibodies. PCR tests demonstrate a sensitivity of 94% and a specificity 99%.
Results
Measles Virus Vaccine Strain | Measles Virus | Interpretation |
---|---|---|
Detected | Not detected | Detection of measles virus vaccine strain RNA indicates that this patient’s symptoms were likely due to vaccine reaction following recent vaccination; individuals with vaccine reactions are not contagious |
Not detected | Detected | Detection of wild-type measles virus RNA is consistent with a diagnosis of measles infection Infected patients are at high risk of transmitting the virus to unimmunized individuals Hospital infection control and a state or local public health laboratory should be notified immediately |
Not detected | Not detected | Negative for measles virus RNA Consider other viral and noninfectious causes for patients who present with rash |
Limitations
- Specimens with low levels of vaccine strain measles virus may be reported as wild type due to the lower sensitivity of the vaccine-specific target (MeVA) compared with the pan-measles virus target (MeV).
- A negative result does not rule out the presence of PCR inhibitors in the patient specimen or assay-specific nucleic acid in concentrations below the level of detection of this assay.
- Serology testing may be indicated if measles is still suspected following a negative result.
- This assay does not enable the definitive identification of wild-type/vaccine strain coinfections.
References
-
CDC - Measles / Rubeola 2013 Case Definition
Centers for Disease Control and Prevention. Measles/rubeola: 2013 case definition. Last reviewed Apr 2021; accessed Oct 2024.
-
CDC - Clinical overview of measles
Centers for Disease Control and Prevention. Clinical overview of measles. Last reviewed July 2024; accessed Sep 2024.
-
Red Book - Measles
Kimberlin D. Measles. In: Bannerjee R, Barnett E, Lynfield R, et al, eds. Red Book: 2024–2027 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2024:570-585.